Beranda › Kanker Kolon › Oklahoma › Oklahoma City
Uji klinis Kanker Kolon di Oklahoma City, OK
6 studi untuk Kanker Kolon mencari peserta di lokasi sekitar Oklahoma City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Family Communications After Genetic Testing
Menerima pesertaSukarelawan sehat diterima
- Mercy Hospital Oklahoma City, Oklahoma City
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Menerima pesertaSukarelawan sehat diterima
- Mercy Hospital Oklahoma City, Oklahoma City
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Menerima pesertaFase 1/2
- University of Oklahoma, Oklahoma City
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Menerima peserta
- Veterans Administration Medical Center - Oklahoma City, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Menerima pesertaFase 2/3
- University of Oklahoma Health Sciences Center, Oklahoma City
- Integris Southwest Medical Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
- dan 1 lainnya
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Menerima pesertaFase 1
- Xencor Investigative Site, Oklahoma City
Uji klinis Kanker Kolon di kota lain
- Boston, MA22 studi
- New York City, NY22 studi
- Houston, TX20 studi
- Los Angeles, CA16 studi
- Nashville, TN16 studi
- St. Louis, MO15 studi
- Arlington, VA15 studi
- Chicago, IL14 studi
- San Antonio, TX14 studi
- Baldwin Park, CA14 studi
- Baltimore, MD13 studi
- Tampa, FL13 studi
Studi lain di Oklahoma City
- Kanker Paru Non-Sel Kecil28 studi
- Kanker Ovarium28 studi
- Kanker Endometrium25 studi
- Kanker Kolorektal22 studi
- Kanker Prostat21 studi
- Kanker Paru19 studi
- Kanker Payudara17 studi
- Kanker Metastatik16 studi
- Kanker (semua jenis)14 studi
- Leukemia Mieloid Akut14 studi
- Karsinoma Sel Skuamosa Kepala dan Leher13 studi
- Kanker Kandung Kemih11 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.